Biomarkers Market Analysis | CMI - PowerPoint PPT Presentation

About This Presentation

Biomarkers Market Analysis | CMI


Read here the latest updates on the Biomarkers Market Analysis published by CMI team – PowerPoint PPT presentation

Number of Views:41


Transcript and Presenter's Notes

Title: Biomarkers Market Analysis | CMI

  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//
  • COVID-19 Impact Tracker

  • Biomarkers Market, by Product Type (Biomarker
    Test Kits, and Biomarker Analyzers), By Disease
    Indication (Cancer, Cardiovascular Disorder,
    Infectious Disease, Neurological Disorder,
    Immunological Disorder and Others), by
    Application (Diagnosis, Drug Discovery and
    Development, and Others ), By End User
    (Hospitals, Research Laboratories, Ambulatory
    Surgical Centers, and Diagnostic Laboratories),
    and by Geography - Global Forecast to 2025.
  • The biomarkers market is estimated to be valued
    at US 29,518.2 Mn in 2017 and is expected to
    witness a robust CAGR of 13.6 during the
    forecast period (2017-2025).

Industry Insights
  • Biomarkers are gaining significant traction in
    product development and treatment of disorders
    related to chromosome structure, Turner syndrome,
    Down syndrome, Patau syndrome, Edwardss
    syndrome, and others, which is propelling demand
    for biomarkers. For instance, in February 2018,
    FDA granted marketing authorization to Banyan
    Biomarkers, Inc. for the first diagnostic blood
    test for traumatic brain injury, Banyan BTI.
    Therefore, introduction of such innovative
    diagnostic tools for various disease indication
    is projected to fuel growth of the Biomarkers
    Market over the forecast period.
  • Moreover, pharmaceutical companies have started
    outsourcing the complex bio analysis not only to
    cut down costs, however, to take advantage of
    specialized expertise to improve efficiency in
    drug development process. For instance, in March
    2018, the SenzaGen signed a key license agreement
    with Burlesson Research Technologies, Inc.,
    (BRT)a contract research organization in the
    U.S., specializing in immunotoxicology. This
    agreement, will provide BRTs 'GARD' to a broader
    market. GARD is a group of tests for assessing
    chemical sensitizers, where the test uses genetic
    biomarkers for over 200 genes, which cover an
    entire immune reaction and are relevant to
    predicting the risk of hypersensitivity. Such
    advancement and innovation by CROs is expected to
    favor growth of biomarkers market in the near

The Global Biomarkers Market Value (US Mn), By
Region (2017)
Market Drivers
  • Increasing application of diagnostic application
    is expected to fuel growth of the global
    biomarkers market
  • Increasing application and awareness about
    biomarker tests is expected to be a major factor
    for growth of the market. Biomarkers are used for
    diagnostics and early detection of specific
    diseases over the conventional diagnostics
    methods. Furthermore, biomarkers such as BRCA1,
    indicates whether an individual has an increased
    likelihood of developing cancer. Biomarkers are
    also applied to a wide variety of therapeutic
    areas, which include neurological diseases,
    metabolic disorders, immune deregulation and
    oncology to treat various disease such as TMI,
    cancer, Alzheimer diagnosis. Biomarkers are also
    used to detect ABO haemolytic disease of new
    born, Huntington disease, and hereditary
    haemochromatosis, and cystic fibrosis.
  • Furthermore, biomarkers are used to detect
    disorder related to chromosome structure such as,
    Turner syndrome, Down syndrome, patau syndrome,
    Edwardss syndrome, and others, which has led to
    increasing demand for biomarkers.

  • Increasing demand for precision medicine to drive
    the growth of the global biomarkers market
  • North America accounts for the largest share in
    the global biomarkers market and this is
    attributed to adoption of precision medicine and
    growing prevalence of cancer in the region.
    According to the National Cancer Institute, 2016,
    it was estimated that 16.8 million new cases of
    cancer were diagnosed in the U.S., with around
    595,690 deaths from cancer disease. The number of
    people suffering from cancer is expected to rise
    to 19 million by 2024, which supports increasing
    demand for precision medicine.
  • Furthermore, the U.S. government in 2015
    announced the launch of Precision Medicine
    Initiative that aimed to revolutionize the
    treatment to improve health, as precision
    medicine is an innovative approach to offer
    tailored treatment. Precision Medicine Initiative
    have led to development of novel drugs and new
    treatments, tailored for specific characteristic
    such as persons genetic makeup or genetic
    profile of an individual tumor that helps to
    transform the way of treatment. This also favors
    growth of the biomarkers market in the near
    future. As for the development of precision
    medicine, it is essential to identify biomarkers.

Key Development
  • Key players are involved in new product launches
    to cater to increasing demand for biomarkers. For
    instance, in 2016 Abbott Laboratories launched
    Point-of-Care i-STAT Alinity, an innovative,
    handheld blood testing platform.

Key Players
  • Some of the other key players in biomarkers
    market include Medtronic plc, BG Medicine, Inc.,
    F. Hoffmann-La Roche Ltd., Seimens Healthnineers,
    Nexus-DX, Qiagen N.V., and Lifesign LLC.

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Reference https//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
  • Phone 1-206-701-6702
  • Email

  • Thank You!
  • Kindly follow CMI Social Media Profiles
    for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//
Write a Comment
User Comments (0)